HDAC3 is a potential validated target for cancer: An overview on the benzamide-based selective HDAC3 inhibitors through comparative SAR/QSAR/QAAR approaches
Year: 2018
Type: article
Language: English
Subfield: Molecular Biology
Domain: Life Sciences
Open Access status: closed
Funder: University Grants Commission
OpenAlex ID: W2888790527
